Navigation Links
Fina Technologies Names Spotfire Founder Christopher Ahlberg to Board of Directors
Date:3/31/2009

CAMBRIDGE, Mass., March 31 /PRNewswire/ -- Fina Technologies, Inc. today announced that it named Dr. Christopher Ahlberg, a pioneering entrepreneur and scientist, and founder of Spotfire, Inc., to its Board of Directors.

Dr. Ahlberg most previously was Executive Vice President, Tibco, Inc., and President of Tibco's Spotfire division, dating back to 2007. Prior to TIBCO, Dr. Ahlberg was the founder and CEO of Spotfire, Inc., a provider of enterprise analytics software for next generation business intelligence and scientific applications. Dr. Ahlberg was named among the World's Top Young Innovators by Technology Review, MIT's Magazine of Innovation, in 2002. Dr. Ahlberg earned his doctorate from Chalmers University of Technology, has worked as a visiting researcher at the University of Maryland, and has lectured and consulted extensively for industry, academia, and the military -- as well as published and lectured in computer science, psychology, linguistics, biology, and chemistry.

"Fina Technologies has a unique opportunity to leverage Gene Network Sciences' REFS(TM) model learning and simulation platform, which has been used in biological systems for several years, to gain an advantage in quantitative finance," said Dr. Ahlberg. "I am looking forward to using my experience with these types of data to help Fina push this application forward."

Dr. Ahlberg also serves as a Board member of Apptus Technologies AB and the Hult International Business School.

"Christopher will be an invaluable asset to Fina, given his experience in building Spotfire, from the startup phase onward," said Josh Holden, CEO of Fina Technologies. "We will fully utilize his insights and intuition as to how to best apply and develop our technology for our applications."

About Fina Technologies

Fina Technologies, Inc. is a spinoff of Gene Network Sciences (GNS) focused on applying the REFS(TM) model learning and simulation platform and other machine-learning tools to large-data problems in the worlds of finance and other non-biomedical areas. Fina Technologies applies massively parallel supercomputing technology combined with cutting edge machine learning techniques to create quantitative trading algorithms and deliver business solutions for a new class of massively data intensive applications.


'/>"/>
SOURCE Fina Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... ... The Pittcon Organizing Committee is pleased to announce that Charles “Chuck” Gardner was named ... 1987. Since then, he has served in a number of key leadership positions including ... program and exposition committees. In his professional career, Dr. Gardner is the director of ...
(Date:4/27/2016)... ... April 27, 2016 , ... The ... announce the appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined ... of the founding commercial leaders responsible for the commercialization of multiple orphan drug ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan Ross, ... Kimera Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology from ... and the suppression of graft vs. host disease (GVHD) under UM Professor Robert Levy ...
(Date:4/26/2016)... ... April 27, 2016 , ... ... Rothgerber Christie LLP as an associate in the firm’s Intellectual Property practice group. ... mechanical and electromechanical patent applications. He has an electrical engineering and computer engineering ...
Breaking Biology Technology:
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/18/2016)... 18, 2016 --> ... ICT, Manned & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance ... in the border security market and the continuing migration crisis ... Europe has led visiongain to publish this ... --> defence & security companies in the ...
(Date:3/14/2016)... Allemagne, March 14, 2016 ... - --> - Renvoi : image disponible ... --> --> DERMALOG, ... fournit de nouveaux lecteurs d,empreintes digitales pour l,enregistrement ... DERMALOG sera utilisé pour produire des cartes d,identité ...
Breaking Biology News(10 mins):